Bullfrog AI Holdings, Inc. — Form 8-K Summary
Reporting date: January 31, 2024; the offering closed on February 5, 2024, and the Form 8-K was signed on February 6, 2024. The filing reports a material financing transaction and related Regulation FD disclosures.
Business Context and Transaction
Bullfrog AI Holdings, Inc. entered into an underwriting agreement with WallachBeth Capital, LLC as representative of the underwriters for a public offering registered under the company’s Form S-1 registration statement.
- Issued or offered 1,028,710 common shares and 478,429 pre-funded warrants in lieu of common shares, representing an aggregate of 1,507,139 shares or pre-funded warrants.
- The securities were sold together with warrants to purchase 1,507,139 shares of common stock.
- Combined public offering price was $3.782 per share, inclusive of the $0.001 exercise price for each pre-funded warrant.
- Gross proceeds were approximately $5.7 million before underwriting discounts, commissions, and other offering expenses, assuming no exercise of the over-allotment option.
- The underwriters received a 45-day option to purchase up to 226,071 additional common shares solely to cover over-allotments.
Financial Metrics and Capitalization Effects
- Gross proceeds: Approximately $5.7 million before offering costs.
- Net proceeds: Not provided in the filing text.
- Revenue, profit, cash flow, margins, debt, and liquidity: The filing does not provide a clear value or updated information for these operating and balance-sheet metrics.
- Potential dilution: The transaction increases shares outstanding or creates potential common-stock issuance through the pre-funded warrants and accompanying warrants. The filing text does not provide the post-offering share count.
- Representative’s warrants: Warrants to purchase 90,428 common shares at an exercise price of $4.16 per share were issued to the representative, equivalent to 110% of the common-stock purchase price.
Material Changes, Outlook, and Risks
The principal material change is the completion of the equity financing and issuance of related warrants. The filing does not provide financial guidance, an operating forecast, or management commentary regarding revenue or profitability.
- Each pre-funded warrant has a $0.001 per-share exercise price, is exercisable upon issuance until exercised in full, and may generally be exercised for cash or on a cashless basis.
- Pre-funded warrant exercises are subject to beneficial-ownership limitations initially set at 4.99%, which may be increased or decreased by the holder, subject to the stated maximum and notice requirements.
- Pre-funded warrants contain customary adjustment provisions for stock dividends, splits, combinations, and similar events, as well as provisions for certain fundamental transactions.
- The underwriting agreement includes customary representations, warranties, closing conditions, indemnification obligations, covenants, and termination provisions.
- Forward-looking statements concerning the offering are subject to risks including market conditions, satisfaction of closing conditions, and the possibility that an offering may not be completed on anticipated terms. The offering ultimately closed on February 5, 2024.
Important Facts for Investors to Verify
- Confirm the final number of common shares, pre-funded warrants, and accompanying warrants issued at closing.
- Verify whether the underwriters exercised any portion of the 226,071-share over-allotment option.
- Review the final net proceeds after underwriting discounts, commissions, and expenses and determine the intended use of proceeds.
- Reconcile the post-offering basic and fully diluted share counts, including all warrant-related dilution.
- Review the warrant agreements for exercise terms, anti-dilution provisions, cashless exercise rights, and ownership limitations.
- Consult the company’s subsequent periodic filings for updated liquidity, operating results, and any risks associated with the financing.